SCHEMBL3148352

SCHEMBL3148352

NC1=NCC(COc2ccc3c(c2)CCCC3)O1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.43
TSHR P16473 1/20 0.43
HSD17B10 Q99714 1/20 0.43
STS P08842 1/20 0.39
SMN1; SMN2 Q16637 5/20 0.39
NPC1 O15118 5/20 0.39
RAB9A P51151 5/20 0.39
ALDH1A1 P00352 2/20 0.39
MAPT P10636 2/20 0.39
HTT P42858 1/20 0.39
RECQL P46063 1/20 0.39
TP53 P04637 1/20 0.38
RXRA P19793 3/20 0.38
RXRB P28702 3/20 0.38
RXRG P48443 3/20 0.38
NFKB1 P19838 1/20 0.38
NFKB2 Q00653 1/20 0.38
RELA Q04206 1/20 0.38
PPARG P37231 1/20 0.37
PPARD Q03181 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3138790 0.97 SMN1; SMN2 (0.41) ALOX15TSHRHSD17B10SMN1; SMN2NPC1
SCHEMBL1495873 0.84 GRM2 (0.48) HSD17B10ALDH1A1MAPT
SCHEMBL1495959 0.81 GRM2 (0.55) HSD17B10ALDH1A1MAPT
SCHEMBL3144469 0.80 RAB9A (0.42) TSHRSMN1; SMN2NPC1RAB9AALDH1A1
SCHEMBL3148324 0.78 DRD4 (0.39) TSHRSMN1; SMN2ALDH1A1TP53
SCHEMBL3138264 0.78 KDM4E (0.38) ALDH1A1
SCHEMBL3149153 0.77 ALDH1A1 (0.33) TSHRHSD17B10SMN1; SMN2ALDH1A1MAPT
SCHEMBL3149165 0.77 ALDH1A1 (0.33) TSHRHSD17B10SMN1; SMN2ALDH1A1MAPT
SCHEMBL7964624 0.77 ALDH1A1 (0.59) ALOX15TSHRHSD17B10STSSMN1; SMN2
SCHEMBL3133660 0.77 ALDH1A1 (0.59) ALOX15TSHRHSD17B10STSSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2137193-B1 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF SANOFI SA (FR) 2017-08-09 EP disclosed
US-8642603-B2 Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof SANOFI (FR) 2014-02-04 US disclosed
US-20100075994-A1 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF SANOFI-AVENTIS (FR) 2010-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075994-A1 SUBSTITUTED DIHYDRO AND TETRAHYDRO OXAZOLOPYRIMIDINONES, PREPARATION AND USE THEREOF GRM2, GRM1, GRIN2C ALOX15 1315/4885TSHR 513/4885HSD17B10 2991/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.